Connection

Evangelos Terpos to Pyrazines

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Pyrazines.
Evangelos Terpos
Connection Strength
0.135
Pyrazines
  1. Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. Am J Hematol. 2015 Apr; 90(4):E60-5.
    View in: PubMed
    Score: 0.066
  2. High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents. Leuk Res. 2010 Mar; 34(3):399-402.
    View in: PubMed
    Score: 0.045
  3. Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021 May; 21(2):167-179.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.